Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets.
Company leaders say they are expanding production and expect big gains in the next several months. That could help if another wave of cases develops.
-copy-dd1f2bf0.jpeg?w=600)
